HomeT1CH34 • BVMF
Bio Techne Corporation Bdr
R$9.12
May 9, 8:00:00 PM GMT-3 · BRL · BVMF · Disclaimer
BR listed securityUS headquartered
Previous close
R$9.12
Year range
R$8.93 - R$16.37
Market cap
7.89B USD
Avg Volume
11.00
In the news
Financials
Income Statement
Revenue
Net income
(USD)Mar 2025Y/Y change
Revenue
316.18M4.20%
Operating expense
175.85M31.81%
Net income
22.59M-53.96%
Net profit margin
7.14-55.84%
Earnings per share
0.5616.67%
EBITDA
66.82M-32.73%
Effective tax rate
40.98%
Total assets
Total liabilities
(USD)Mar 2025Y/Y change
Cash and short-term investments
140.67M-3.19%
Total assets
2.64B-2.83%
Total liabilities
626.23M-11.40%
Total equity
2.02B
Shares outstanding
157.37M
Price to book
0.71
Return on assets
3.69%
Return on capital
3.99%
Net change in cash
(USD)Mar 2025Y/Y change
Net income
22.59M-53.96%
Cash from operations
41.12M-49.23%
Cash from investing
-8.87M46.03%
Cash from financing
-68.04M-29.82%
Net change in cash
-36.88M-476.97%
Free cash flow
19.91M-65.26%
About
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets. Wikipedia
Founded
1976
Employees
3,100
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu